Condition

Advanced Lung Carcinoma

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting4
Common interventions25
Lead sponsors shown11
Advertisement

Clinical trials

17 shown
BBO-11818 in Adult Subjects With KRAS Mutant CancerNCT06917079 · 2025-03-31
RECRUITING
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung CancerNCT05705492 · 2024-07-17
RECRUITING
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerNCT06343402 · 2024-05-22
RECRUITING
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerNCT05969860 · 2023-08-23
RECRUITING
Exercise in Patients With Advanced Non-small Cell Lung CancerNCT06374160 · 2024-05-01
UNKNOWN
A Biomarker Screening Protocol for Participants With Solid TumorsNCT05891197 · 2023-05-19
TERMINATED
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR MutationsNCT05256290 · 2022-03-31
ACTIVE_NOT_RECRUITING
A Study to Investigate LYL797 in Adults With Solid TumorsNCT05274451 · 2022-03-29
TERMINATED
A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung CancerNCT04924192 · 2021-08-18
TERMINATED
A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung CancerNCT05342571 · 2021-06-01
COMPLETED
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesNCT04785287 · 2021-03-29
TERMINATED
A Nurse-Led Intervention for Fear of Progression in Advanced CancerNCT04819997 · 2021-03-08
ACTIVE_NOT_RECRUITING
BeWell360-CG Care Model: Health and Wellness Coaching to Support Caregivers of Patients Living With Advanced Lung CancersNCT05640765 · 2021-02-03
COMPLETED
Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung CancerNCT04702009 · 2021-01-20
COMPLETED
Resiliency Among Older Adults Receiving Lung Cancer TreatmentNCT04229381 · 2020-01-22
COMPLETED
Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerNCT03707938 · 2018-12-18
ACTIVE_NOT_RECRUITING
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic CancerNCT03776253 · 2018-11-15
COMPLETED

Common interventions

Trial status mix

COMPLETED5
RECRUITING4
TERMINATED4
ACTIVE_NOT_RECRUITING3
UNKNOWN1

Phase mix

NA6
PHASE16
PHASE26
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.